Clinical trial
Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma
NCT00425061 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00425061 |
|---|---|
| Title | Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma |
| Official title | Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study Conducted Sequentially With 3 Doses Of Ima-638 Administered Sc. |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Biological, Other |
| Interventions | IMA-638, placebo |
| Enrollment | 159 |
| Start date | Feb 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jan 22, 2007 |
| Last update posted | Jan 14, 2015 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: